| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director
2 companies
Davis Stephen is a CEO at ACADIA PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2021 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 3,484 | $53.34 | $185,836.56 | -12.5% | |
| Oct 16, 2020 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 2,960 | $42.56 | $125,977.60 | -16.7% | |
| May 14, 2020 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 200,000 | $46.02 | $9,204,691.76 | -35.9% | |
| Apr 30, 2020 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 6,770 | $49.21 | $333,151.70 | -36.4% | |
| Dec 5, 2019 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 150,000 | $52.34 | $7,851,299.93 | -58.7% | |
| Oct 15, 2019 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 2,983 | $39.65 | $118,275.95 | -50.2% | |
| Oct 10, 2019 | ACAD Acadia Pharmaceuticals Inc | CEO | Sale+OE | 150,000 | $40.15 | $6,022,749.10 | -100% |